Sign up for free insights newsletter
LN

LNA Sante SA

LNAEuronext Paris

Need professional-grade analysis? Visit stockanalysis.com

€29.00
+0.00%
End of day
Market Cap

$298.56M

P/E Ratio

12.34

Employees

8,282

Dividend Yield

2.93%

Price Chart

Risk-Adjusted Performance

Ratio1W1M3M6M1Y5YScore
Sortino8.564.041.68-0.352.85
Calmar20.407.720.99-0.125.67
Sharpe6.8317.794.292.381.04-0.253.44
Omega19.841.931.531.240.983.30
Martin42.3215.721.64-0.1711.60
Ulcer0.000.172.693.9517.8748.6417.84

LNA Sante SA (LNA) Price Performance

LNA Sante SA (LNA) trades on Euronext Paris in EUR. The company is classified in the Healthcare sector under the Medical Care Facilities industry. The stock currently trades at EUR29.00.

Over the past year, LNA has traded between a low of EUR22.13 and a high of EUR32.20. The stock has gained 31.0% over this period. It is currently 9.9% below its 52-week high.

LNA Sante SA has a market capitalization of $298.56M, with a price-to-earnings ratio of 12.34 and a dividend yield of 2.93%.

About LNA Sante SA

LNA Santé SA engages in the management and operation of healthcare facilities and medical residences for able-bodied, semi-dependent, or dependent elderly people in France. The company operates medical care and rehabilitation units; mental health clinics; health centres; and care homes. It also provides respiratory assistance and rehabilitation, cancerology, diabetology, pain management, therapeutic education for the patient and his/her family, geriatrics, enteral and parenteral nutrition, obstetrics, antenatal and postnatal, complex dressings and specific care, post-operative care, anti-cancer chemotherapy, post-chemotherapy, radiotherapy and aplasia monitoring, psychological or social care, neurological and orthopedic rehabilitation, palliative care, intensive nursing care, intravenous treatment/infusion, blood transfusion, education for the patient and his/her loved ones, paracentesis, pleural or peritoneal drainage, and other treatment services. In addition, the company offers general, ENT carcinological, digestive and urology, dental, spinal, cosmetic, gynecological and obstetric, maxillo-facial, eye, ENT, orthopedic and trauma, plastic and cosmetic facial, stomatological, urological, vascular, and visceral and digestive surgery, as well as digestive endoscopies and hepato-gastroenterology services. LNA Santé SA was founded in 1990 and is based in Vertou, France.

Compare LNA Sante SA

Side-by-side comparison against top Healthcare peers.

Company Info

Exchange
Euronext Paris
Currency
EUR
Country
France

Financial Metrics

Revenue (TTM)
$912.67M
EBITDA
$97.37M
Profit Margin
2.65%
EPS (TTM)
2.35
Book Value
31.08

Technical Indicators

52 Week High
€32.70
52 Week Low
€22.13
50 Day MA
€26.71
200 Day MA
€25.88
Beta
0.48

Valuation

Trailing P/E
12.34
Forward P/E
12.41
Price/Sales
0.33
Price/Book
0.90
Enterprise Value
$1.11B